Protect Our Care: GREED WATCH: AstraZeneca announces over $45 billion in revenue

AstraZeneca announced it raked in $45.5 billion in 2023 – a $1.46 billion increase over 2022 – during their earnings report last week. While they make billions, drug companies charge Americans over four times more for prescription drugs than customers in other high-income countries.

During the call, CEO Pascal Soriot underscored his company’s greed in suing the Biden administration to block Medic...